Sandra Ferry, Degli Esposti Mauro, Ndebele Kenneth, Gona Philimon, Knight David, Rosenquist Magnus, Khosravi-Far Roya
Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
Cancer Res. 2005 Sep 15;65(18):8286-97. doi: 10.1158/0008-5472.CAN-04-1913.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to have selective antitumor activity. TRAIL induces ubiquitous pathways of cell death in which caspase activation is mediated either directly or via the release of apoptogenic factors from mitochondria; however, the precise components of the mitochondrial signaling pathway have not been well defined. Notably, mitochondria constitute an important target in overcoming resistance to TRAIL in many types of tumors. Bid is considered to be fundamental in engaging mitochondria during death receptor-mediated apoptosis, but this action is dependent on mitochondrial lipids. Here, we report that TRAIL signaling induces an alteration in mitochondrial membrane lipids, particularly cardiolipin. This occurs independently of caspase activation and primes mitochondrial membranes to the proapoptotic action of Bid. We unveil a link between TRAIL signaling and alteration of membrane lipid homeostasis that occurs in parallel to apical caspase activation but does not take over the mode of cell death because of the concurrent activation of caspase-8. In particular, TRAIL-induced alteration of mitochondrial lipids follows an imbalance in the cellular homeostasis of phosphatidylcholine, which results in an elevation in diacylglycerol (DAG). Elevated DAG in turn activates the delta isoform of phospholipid-dependent serine/threonine protein kinase C, which then accelerates the cleavage of caspase-8. We also show that preservation of phosphatidylcholine homeostasis by inhibition of lipid-degrading enzymes almost completely impedes the activation of pro-caspase-9 while scarcely changing the activation of caspase-8.
肿瘤坏死因子相关凋亡诱导配体(TRAIL)已被证明具有选择性抗肿瘤活性。TRAIL可诱导普遍存在的细胞死亡途径,其中半胱天冬酶的激活可直接介导或通过线粒体释放凋亡因子来介导;然而,线粒体信号通路的确切组成部分尚未明确界定。值得注意的是,线粒体是克服多种肿瘤对TRAIL耐药性的重要靶点。Bid被认为在死亡受体介导的细胞凋亡过程中参与线粒体功能发挥着重要作用,但这种作用依赖于线粒体脂质。在此,我们报道TRAIL信号传导会诱导线粒体膜脂质发生改变,尤其是心磷脂。这种改变独立于半胱天冬酶激活发生,并使线粒体膜对Bid的促凋亡作用产生致敏。我们揭示了TRAIL信号传导与膜脂质稳态改变之间的联系,这种改变与顶端半胱天冬酶激活同时发生,但由于半胱天冬酶-8的同时激活,不会取代细胞死亡模式。特别是,TRAIL诱导的线粒体脂质改变是由于磷脂酰胆碱细胞稳态失衡导致二酰甘油(DAG)升高引起的。升高的DAG进而激活磷脂依赖性丝氨酸/苏氨酸蛋白激酶C的δ亚型,从而加速半胱天冬酶-8的裂解。我们还表明,通过抑制脂质降解酶来维持磷脂酰胆碱稳态几乎完全阻碍了前半胱天冬酶-9的激活,而对半胱天冬酶-8的激活几乎没有影响。